Ensign Peak Advisors, Inc
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1454984
SALT LAKE CITY, UT
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$174,500
+$37,412 QoQ
Shares Held
17,450
+21.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#214
of 316 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $86,377,339 across 19 Drug Manufacturers - Specialty & Generic names. BCRX ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,946 | $29,653,938 | |
| 2 | ALKS |
Alkermes plc.
|
335,208 | $17,564,899 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
26,450 | $14,331,403 | |
| 4 | ZTS |
Zoetis Inc.
|
126,706 | $9,105,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
305,441 | $5,485,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
141,698 | $3,473,017 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,081 | $2,339,943 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,383,998 |
All Filings in BCRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,500 | 17,450 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $137,088 | 14,400 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $112,320 | 14,400 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $355,212 | 46,800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $792,064 | 88,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $663,000 | 88,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $664,768 | 88,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $671,840 | 88,400 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $546,312 | 88,400 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $449,072 | 88,400 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $556,231 | 92,860 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $657,448 | 92,860 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $653,734 | 92,860 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $774,452 | 92,860 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $936,308 | 81,560 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $672,336 | 53,360 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $548,361 | 51,830 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $842,755 | 51,830 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $717,845 | 51,830 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||